OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) — Stella

Home/Hypertension/

View on ClinicalTrials.gov

Recruiting

Back to Hypertension trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Case Western Reserve University, Cleveland, Ohio

Key details

Sponsor

Case Western Reserve University

Collaborators

University Hospitals Cleveland Medical Center

Enrollment target

~208 participants

Started

February 2021

Primary completion

May 2027

Age range

50 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.